Edesa Biotech Inc. (NASDAQ: EDSA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EDESA BIOTECH INC.

Edesa Biotech Inc. (NASDAQ: EDSA)
Listen to this Section


$5.52
-1.5700 ( -22.10% ) 544.5K

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Market Data


Open $5.52
Previous Close $7.09
Volume 544.5K
Market Cap $61.00M
Day Range $5.25 - $8.24
52 Week Range $0.72 - $20.32
Shares Outstanding 8.89M
Change % -22.10%
Net Change ▼ -1.5700
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryPharmaceuticals and Biotechnology
IPO Year2010
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -232,004.00

Date Type Amount Purchased Purchaser
2024-08-02 Sale -3317.00 Nijhawan Pardeep
2024-07-03 Sale -4015.00 Nijhawan Pardeep
2024-06-04 Sale -4785.00 Nijhawan Pardeep
2024-05-01 Sale -3083.00 Nijhawan Pardeep
2024-04-02 Sale -3253.00 Nijhawan Pardeep
2024-03-25 Buy 5000.00 Nijhawan Pardeep
2024-03-01 Sale -2765.00 Nijhawan Pardeep
2024-02-02 Sale -2978.00 Nijhawan Pardeep
2024-01-12 Sale -2908.00 Nijhawan Pardeep
2023-08-04 Sale -17400.00 Lemieux Stephen

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 1 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 2 Jun 02, 2025
4 Insider transactions 1 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy